Qp/Qs in Single Ventricle: Bedside Approximation

Qp/Qs in Single Ventricle: Bedside Approximation

image

In single-ventricle physiology, the pulmonary and systemic circulations are arranged in parallel rather than in series. Systemic venous return and pulmonary venous return mix within a common ventricular chamber, and the single ventricle ejects blood to both the pulmonary and systemic circulations. As a result, the balance between pulmonary blood flow (Qp) and systemic blood flow (Qs) is a central determinant of systemic oxygen delivery, ventricular workload, and end-organ perfusion. In this setting, the hemodynamic goal is not simply to achieve a higher arterial oxygen saturation, but to maintain the most favorable distribution of flow for systemic oxygen transport [1].

1. Classical concept of Qp/Qs estimation

The conventional relationship is expressed as follows:

Qp/Qs = (SaO2 − SvO2) / (SpvO2 − SpaO2)

where SaO2 is systemic arterial oxygen saturation, SvO2 is systemic venous oxygen saturation, SpvO2 is pulmonary venous oxygen saturation, and SpaO2 is pulmonary arterial oxygen saturation. In single-ventricle parallel circulation, this equation is often simplified at the bedside by assuming that systemic arterial saturation is approximately equal to pulmonary arterial saturation, and that pulmonary venous saturation is nearly 100% in the absence of significant lung disease. Additional bedside approximations frequently assume a relatively fixed arteriovenous oxygen saturation difference, often around 20% to 25% [2].

These assumptions make rapid estimation attractive, but they also create the major weakness of saturation-based bedside Qp/Qs calculation: the method appears simple precisely because it ignores variables that are often unstable in critically ill single-ventricle patients.

2. Why oxygen saturation alone can be misleading

A major teaching point is that bedside Qp/Qs estimation based on arterial oxygen saturation alone is inherently unreliable. Barnea and colleagues demonstrated that attempts to estimate Qp/Qs or systemic oxygen delivery from oxygen saturation measurements may lead to substantial error, particularly when pulmonary venous oxygen saturation is not actually known [2]. This is not a minor technical limitation. In postoperative or unstable single-ventricle physiology, pulmonary venous saturation may be reduced by atelectasis, pulmonary edema, pleural disease, ventilation-perfusion mismatch, or other forms of impaired gas exchange. Under such circumstances, the simplifying assumption of SpvO2 = 100% becomes invalid, and the bedside estimate can be significantly distorted [2,5].

In addition, arterial oxygen saturation alone is an insensitive marker of circulatory maldistribution. Riordan and colleagues emphasized that venous oxygen saturation correlates much more closely with both Qp/Qs and systemic oxygen delivery, whereas arterial oxygen saturation does not accurately predict either variable [4]. From a physiologic standpoint, this is logical: arterial saturation may remain deceptively acceptable despite progressive systemic hypoperfusion, because higher pulmonary blood flow can increase SaO2 even while systemic oxygen transport is deteriorating.

This is the classic paradox of single-ventricle parallel circulation: a higher SaO2 may reflect worsening pulmonary overcirculation rather than improved systemic hemodynamics [1,2,4].

3. The importance of systemic venous oxygen saturation

Because systemic venous oxygen saturation reflects the balance between oxygen delivery and tissue oxygen consumption, it provides more direct information about the adequacy of systemic perfusion than arterial saturation alone. Riordan et al. reported the clinical usefulness of monitoring systemic venous oxygen saturation in hypoplastic left heart syndrome, highlighting its value in detecting physiologic deterioration that may not be apparent from arterial saturation alone [3]. Subsequent clinical work further reinforced this principle, showing that mixed or systemic venous saturation is a practical surrogate for systemic oxygen delivery in early Norwood-type physiology [6,7].

This concept is clinically important. In a patient with parallel circulation, an SpO2 of 90% may appear reassuring at first glance. However, if that higher SaO2 is accompanied by a fall in SvO2, the actual interpretation is not hemodynamic improvement but increased pulmonary runoff at the expense of systemic flow. Conversely, a modest systemic saturation may be entirely acceptable if systemic venous saturation, perfusion, urine output, lactate trend, and regional oxygenation suggest adequate systemic oxygen delivery.

Thus, SvO2 is not merely another saturation number; it is a more meaningful physiologic guide to whether the circulation is serving the body effectively [3,4,6,7].

4. Optimal Qp/Qs is not necessarily 1:1

Another important refinement is that the ideal Qp/Qs ratio is not simply “equal flows.” Barnea et al. showed theoretically that the optimal Qp/Qs ratio for maximizing systemic oxygen availability in hypoplastic left heart syndrome is generally less than or equal to 1, not substantially above it [1]. Their model also demonstrated that systemic oxygen availability may decline steeply once the circulation moves beyond critical thresholds. In other words, the relationship is not broad and forgiving; it may be sharply nonlinear, with relatively small hemodynamic shifts producing major changes in oxygen delivery [1].

This helps explain why some single-ventricle patients can deteriorate abruptly despite apparently acceptable arterial saturations. A circulation with excessive pulmonary blood flow may still produce a visually “good” pulse oximetry number while sitting very close to a physiologic cliff in terms of systemic oxygen transport.

5. Pulmonary venous desaturation as a hidden source of error

A further limitation of bedside Qp/Qs approximation is that pulmonary venous desaturation is often unrecognized. Taeed and colleagues demonstrated that early after Norwood palliation, pulmonary venous desaturation occurs frequently enough to confound Qp/Qs assessment and compromise oxygen delivery [5]. This finding is particularly important because many bedside formulas implicitly assume normal pulmonary venous saturation. Once that assumption fails, the equation may no longer reflect the true balance of pulmonary and systemic flow.

Accordingly, saturation-based estimation should always be interpreted in the context of the respiratory state. If the patient has atelectasis, pulmonary edema, low lung volumes, secretion burden, pleural effusion, or significant parenchymal disease, then the reliability of SaO2-based Qp/Qs estimation falls substantially. In such settings, a higher FiO2 or recruitment strategy may improve oxygen delivery not necessarily by improving Qp/Qs, but by correcting occult pulmonary venous desaturation [5].

6. SaO2 and SvO2 are both useful, but neither alone is complete

Although SvO2 is superior to SaO2 as a bedside guide to systemic oxygen delivery, it is still not a perfect standalone variable. Yuki and colleagues showed mathematically that SaO2 or SvO2 alone does not accurately predict either DO2 or Qp/Qs in transitional single-ventricle physiology [8]. Their analysis suggested that the oxygen excess factor, defined as SaO2 / (SaO2 − SvO2), provides a more linear and more physiologically informative relationship with systemic oxygen delivery [8].

This is an important modern nuance. The bedside lesson is not that SaO2 is useless and SvO2 is sufficient in every circumstance. Rather, the lesson is that isolated arterial oxygen saturation is weak, systemic venous saturation is more informative, and integrated indices that incorporate both arterial and venous saturation may better reflect true oxygen transport physiology [2,4,8].

7. Practical bedside implications

From a clinical standpoint, several principles follow:

  1. Do not interpret a high arterial saturation in isolation.
  2. In single-ventricle physiology, a higher SaO2 may indicate excessive pulmonary blood flow and reduced systemic perfusion rather than improvement [1,2,4].

  3. Use systemic venous oxygen saturation whenever possible.
  4. SvO2 provides better insight into the adequacy of systemic oxygen delivery and can reveal hemodynamic compromise earlier than SaO2 alone [3,4,6,7].

  5. Be cautious when pulmonary venous saturation is assumed rather than measured.
  6. Occult pulmonary venous desaturation is common enough to create major errors in Qp/Qs estimation [2,5].

  7. Remember that optimal Qp/Qs is usually at or below 1.
  8. Pulmonary overcirculation may sharply reduce systemic oxygen availability despite apparently good oxygenation [1].

  9. Interpret all saturation data within the broader hemodynamic context.
  10. Lactate, urine output, capillary refill, blood pressure, pulse pressure, NIRS, ventricular function, hemoglobin concentration, and respiratory mechanics remain essential for correct interpretation.

8. Clinical takeaway

Bedside Qp/Qs estimation can be a useful conceptual tool in single-ventricle physiology, but it should not be mistaken for a precise measurement when based on oxygen saturation alone. The classical shortcut is attractive because it is simple, yet the physiology is often more complex than the assumptions permit. Variability in pulmonary venous saturation, systemic oxygen extraction, and intracardiac or extracardiac flow distribution can produce substantial error. For this reason, arterial oxygen saturation alone should not be used as the primary guide for circulatory optimization [2,4,5].

A more physiologically sound approach is to prioritize systemic oxygen delivery, using systemic venous oxygen saturation as a key bedside marker and recognizing that integrated indices such as the oxygen excess factor may provide additional insight [3,6-8]. In practical terms, the target is not the prettiest saturation number, but the circulation that best preserves end-organ oxygen transport.

References

[1] Barnea O, Austin EH, Richman B, Santamore WP. Balancing the circulation: theoretic optimization of pulmonary/systemic flow ratio in hypoplastic left heart syndrome. J Am Coll Cardiol. 1994;24(5):1376-1381.

[2] Barnea O, Santamore WP, Rossi A, Salloum E, Chien S, Austin EH. Estimation of oxygen delivery in newborns with a univentricular circulation. Circulation. 1998;98(14):1407-1413.

[3] Riordan CJ, Locher JP, Santamore WP, Villafane J, Austin EH. Monitoring systemic venous oxygen saturation in the hypoplastic left heart syndrome. Ann Thorac Surg. 1997;63(3):835-837.

[4] Riordan CJ, Randsbaek F, Storey JH, Montgomery WD, Santamore WP, Austin EH. Effects of oxygen, positive end-expiratory pressure, and carbon dioxide on oxygen delivery in an animal model of the univentricular heart. J Thorac Cardiovasc Surg. 1996;112(3):644-654.

[5] Taeed R, Schwartz SM, Pearl JM, Raake JL, Beekman RH 3rd, Manning PB, Nelson DP. Unrecognized pulmonary venous desaturation early after Norwood palliation confounds Qp/Qs assessment and compromises oxygen delivery. Circulation. 2001;103(22):2699-2704.

[6] Tweddell JS, Ghanayem NS, Mussatto KA, Mitchell ME, Lamers LJ, Musa NL, et al. Mixed venous oxygen saturation monitoring after stage 1 palliation for hypoplastic left heart syndrome. Ann Thorac Surg. 2007;84(4):1301-1311.

[7] Hoffman GM, Mussatto KA, Brosig CL, Ghanayem NS, Musa N, Fedderly RT, et al. Systemic venous oxygen saturation after the Norwood procedure and childhood neurodevelopmental outcome. J Thorac Cardiovasc Surg. 2005;130(4):1094-1100.

[8] Yuki K, Emani S, DiNardo JA. A mathematical model of transitional circulation toward biventricular repair in hypoplastic left heart syndrome. Anesth Analg. 2012;115(3):618-626.